Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Premier, Inc. (PINC) Tops Q1 Earnings and Revenue Estimates
Premier, Inc. (PINC) Tops Q1 Earnings and Revenue Estimates

Premier, Inc. (PINC) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.34 per share a year ago. These

Viridian Therapeutics, Inc. (VRDN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Viridian Therapeutics, Inc. (VRDN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

The market expects Viridian Therapeutics, Inc. (VRDN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This

Sky Harbour Group Corporation (SKYH) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Sky Harbour Group Corporation (SKYH) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

The market expects Sky Harbour Group Corporation (SKYH) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025

SKYX Platforms Corp. (SKYX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
SKYX Platforms Corp. (SKYX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when SKYX Platforms Corp. (SKYX) reports results for the quarter ended September 2025. While this widely-known

Will Plug Power (PLUG) Report Negative Q3 Earnings? What You Should Know
Will Plug Power (PLUG) Report Negative Q3 Earnings? What You Should Know

The market expects Plug Power (PLUG) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus

Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Wall Street expects a year-over-year increase in earnings on higher revenues when Ovid Therapeutics (OVID) reports results for the quarter ended September 2025. While this widely-known consensus

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Orchestra BioMed Holdings, Inc. (OBIO) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known

Ondas Holdings Inc. (ONDS) Expected to Beat Earnings Estimates: Should You Buy?
Ondas Holdings Inc. (ONDS) Expected to Beat Earnings Estimates: Should You Buy?

The market expects Ondas Holdings Inc. (ONDS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known

Compared to Estimates, NNN REIT (NNN) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, NNN REIT (NNN) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, NNN REIT (NNN) reported revenue of $229.77 million, up 5.3% over the same period last year. EPS came in at $0.86, compared to $0.53 in the year-ago quarter.

The

HIVE Digital Technologies (HIVE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
HIVE Digital Technologies (HIVE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wall Street expects a year-over-year increase in earnings on higher revenues when HIVE Digital Technologies (HIVE) reports results for the quarter ended September 2025. While this widely-known

Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Fate Therapeutics (FATE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

Bolt Biotherapeutics, Inc. (BOLT) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known

Compared to Estimates, Hertz Global (HTZ) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Hertz Global (HTZ) Q3 Earnings: A Look at Key Metrics

Hertz Global Holdings, Inc. (HTZ) reported $2.48 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 3.8%. EPS of $0.12 for the same period compares to

Marriott (MAR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Marriott (MAR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, Marriott International (MAR) reported revenue of $6.49 billion, up 3.7% over the same period last year. EPS came in at $2.47, compared to $2.26 in the year-ago

Opus Genetics, Inc. (IRD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Opus Genetics, Inc. (IRD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

The market expects Opus Genetics, Inc. (IRD) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known

Hamilton Lane (HLNE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Hamilton Lane (HLNE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, Hamilton Lane (HLNE) reported revenue of $190.88 million, up 27.3% over the same period last year. EPS came in at $1.54, compared to $1.07 in the year-ago

Evolution Petroleum (EPM) Reports Next Week: What You Should Expect
Evolution Petroleum (EPM) Reports Next Week: What You Should Expect

Wall Street expects flat earnings compared to the year-ago quarter on lower revenues when Evolution Petroleum (EPM) reports results for the quarter ended September 2025. While this widely-known

Integral Ad Science (IAS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Integral Ad Science (IAS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Integral Ad Science (IAS) reported $154.36 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 15.6%. EPS of $0.07 for the same period compares to

Here's What Key Metrics Tell Us About Pfizer (PFE) Q3 Earnings
Here's What Key Metrics Tell Us About Pfizer (PFE) Q3 Earnings

For the quarter ended September 2025, Pfizer (PFE) reported revenue of $16.65 billion, down 5.9% over the same period last year. EPS came in at $0.87, compared to $1.06 in the year-ago quarter.

The

Analysts Estimate CAE (CAE) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate CAE (CAE) to Report a Decline in Earnings: What to Look Out for

CAE (CAE) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives a good

Bet on These 3 Retail REITs as the Sector Shows Renewed Strength
Bet on These 3 Retail REITs as the Sector Shows Renewed Strength
The Zacks REIT and Equity Trust - Retail industry is showing renewed resilience as landlords adapt and reposition assets for long-term stability. Strategic re-tenanting, a focus on necessity-based
Implied Volatility Surging for A. O. Smith Stock Options
Implied Volatility Surging for A. O. Smith Stock Options

Investors in A. O. Smith Corporation AOS need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $40.00 Call had some of the highest

Navitas Stock Declines 9% on Q3 Loss, Revenues Fall Y/Y
Navitas Stock Declines 9% on Q3 Loss, Revenues Fall Y/Y

Navitas Semiconductor (NVTS) shares dropped 9% after reporting third-quarter 2025 results on Monday (Nov. 3). Navitas shares have appreciated 198.1% year to date, outperforming the broader Zacks

Best Momentum Stocks to Buy for Nov. 4
Best Momentum Stocks to Buy for Nov. 4

Here is a stock with buy rank and strong momentum characteristics for investors to consider today, Nov. 4:

Logitech International S.A. LOGI: This software-enabled hardware solutions company has a

Somnigroup International (SGI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Somnigroup International (SGI) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Shares of Somnigroup International (SGI) have been struggling lately and have lost 5.5% over the past two weeks. However, a hammer chart pattern was formed in its last trading session, which could